From: Design of study without drugs—a Surinamese school-based drug-prevention program for adolescents
Country | Lifetime prevalence | Past-year prevalence | Past-month prevalence |
---|---|---|---|
Antigua and Barbuda | 23.94 | 12.88 | 8.05 |
Barbados | 18.97 | 11.42 | 6.88 |
Dominica | 29.54 | 17.47 | 11.62 |
Grenada | 25.43 | 14.44 | 7.75 |
Guyana | 12.12 | 6.87 | 3.97 |
Haiti | 2.20 | 1.05 | 0.63 |
Jamaica | 21.56 | 12.04 | 7.06 |
St Kitts and Nevis | 24.14 | 12.85 | 6.94 |
St Lucia | 26.51 | 16.49 | 9.46 |
St Vincent and the Grenadines | 20.13 | 12.92 | 5.82 |
Suriname | 5.53 | 3.29 | 2.02 |
Trinidad and Tobago | 12.09 | 6.44 | 2.70 |
Average | 17.03 | 9.76 | 5.39 |